Because insulin resistance is directly involved in excess hepatic fat accumulation, many types of insulin sensitizers were tested and histological benefits of thiazolidinediones were demonstrated in patients with NASH [29]. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.